News | April 2020

Diabetes supply availability during COVID-19 pandemic

 

To better understand the real impact of COVID-19 on diabetes medication and supply availability, we surveyed members of our US Patient Community earlier this week about their recent experiences refilling their prescriptions.

Over 4,700 people completed our survey in 48 hours. We also asked about the changes they expect to make to how they get their supplies because of COVID-19, and about how the pandemic has affected them so far.

While global diabetes supply chains have not been disrupted by COVID-19, there have been reports of short-term delays, people‚Äôs normal routines have been upended, and it has become more difficult (and risky) for people to visit pharmacies, stores, and doctors’ offices in-person to get the supplies and care they need.

For a PDF version of the report, please complete the form below and we’ll email you within 48 hours.

We will continue to track the experiences and opinions of people with diabetes throughout the pandemic, and welcome your feedback and comments. If you have suggestions for questions we could be asking or would like to learn more, please let us know.

Click here to sign up for the dQ&A Newsletter, to receive our latest research findings in your inbox.